XTRA:RDCConsumer Retailing
Assessing Redcare Pharmacy (XTRA:RDC) Valuation After 18.3% Q1 2026 Revenue Growth
Redcare Pharmacy (XTRA:RDC) reported preliminary first quarter 2026 group revenue of €848 million, up 18.3% year on year, supported by higher non-prescription sales in Germany and continued prescription momentum in Germany and Switzerland.
See our latest analysis for Redcare Pharmacy.
The strong first quarter revenue update and recent Supervisory Board appointments have coincided with a sharp rebound in momentum, with Redcare Pharmacy’s 30 day share price return of 55.54% contrasting with a 1...